An Open-label, Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Subjects With Cutaneous Adverse Events Due to Checkpoint Inhibitors
Clinical trial NCT07639840 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07639840
- Sponsor
- Massachusetts General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.